Molecular mechanisms of peritoneal dissemination of ovarian cancer cell, based on the analysis of its microenvironment

基于微环境分析的卵巢癌细胞腹腔播散的分子机制

基本信息

  • 批准号:
    13470349
  • 负责人:
  • 金额:
    $ 9.22万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

Ovarian carcinoma is the leading cause of gynecological cancer death. The poor prognosis for patients with ovarian cancer is related with peritoneal dissemination; a metastatic process in which cancer cells detach from the primary tumor, attach to the peritoneum, and re-grow at the site. The objective of this study is to explore the molecular mechanisms of peritoneal dissemination of ovarian cancer cells, based on the analysis of the microenvironment of disseminating cancer cells.Analysis of pH, pO2 and pCO2 of malignant ascitic or ovarian tumor fluids disclosed hypoxic environment of ovarian cancer cells. In addition, immunohistochemical study on the expression and hypoxia-inducible factor-1 alpha (HIF-1 alpha) showed that HIF-1 alpha is localized in the nuclei of tumor cells at the periphery of papillary projection. These findings indicate that ovarian cancer cells are exposed to hypoxia at the initial step of peritoneal dissemination.cDNA microarray analysis demonstrated that hypoxi … More a down-regulates the expression of cell adhesion molecules, E-cadherin and beta-catenin, in ovarian cancer cells. In ovarian carcinoma tissues, the tumor cells positive for HIF-1 alpha tended to lose E-cadherin expression. Northern blot and Western blot analyses also showed that hypoxia attenuates the expression of E-cadherin in ovarian cancer cells, via up-regulation of SNAL, a transcriptional represser of E-cadherin. Therefore, it is likely that hypoxic microenvironment plays an important role in the attenuation of cell adhesion and transformation into "metastatic phenotype" of cancer cells.Our study on the expression of ras-related GTPases Rho in epithelial ovarian tumors revealed that it was elevated in ovarian carcinomas compared with benign tumors. In addition, its expression at mRNA and protein levels was significantly higher in the peritoneal dissemination than in the primary lesion. Up-regulation and activation of Rho by treatment with lysophospahtidic acid (LPA) increased the in vitro invasiveness of ovarian cancer cells, and treatment with C3 exoenzyme, a specific inhibitor of Rho, reversed the effect of LPA treatment. Ex vivo model using nude mice showed that peritoneal dissemination was more prominent in ovarian cancer cells expressing Rho constitutively. These findings indicate that up-regulation of Rho is essential in the tumor progression of ovarian carcinoma, and will be a molecular target in the future therapy. Less
卵巢癌是妇科癌症死亡的主要原因,卵巢癌患者的不良预后与腹膜播散有关;在该过程中,癌细胞从原发肿瘤脱落,附着在腹膜上,并在该部位重新生长。本研究的目的是在分析癌细胞播散的微环境的基础上,探讨卵巢癌细胞腹腔播散的分子机制。恶性腹水或卵巢肿瘤液体的pO2和pCO2揭示了卵巢癌细胞的缺氧环境。此外,对缺氧诱导因子1α(HIF-1α)的表达和免疫组织化学研究表明,HIF-1α定位于卵巢癌细胞。这些发现表明,卵巢癌细胞在腹膜的初始阶段就暴露在缺氧环境中。 cDNA微阵列分析表明,缺氧会下调卵巢癌细胞中细胞粘附分子E-钙粘蛋白和β-连环蛋白的表达。在卵巢癌组织中,HIF-1α阳性的肿瘤细胞倾向于表达。 Northern blot 和 Western blot 分析还表明,缺氧会通过上调 E-cadherin 的表达来减弱卵巢癌细胞中 E-cadherin 的表达。 SNAL是E-钙粘蛋白的转录抑制因子,因此,缺氧微环境很可能在细胞粘附减弱和癌细胞向“转移表型”转化中发挥重要作用。我们对ras相关GTPase Rho表达的研究。在上皮性卵巢肿瘤中,与良性肿瘤相比,其在卵巢癌中的表达升高。此外,其在腹膜中的 mRNA 和蛋白质水平的表达显着升高。溶血磷脂酸 (LPA) 治疗上调和激活 Rho 增加了卵巢癌细胞的体外侵袭性,而 Rho 特异性抑制剂 C3 外切酶治疗则逆转了 LPA 治疗的效果。使用裸鼠的离体模型表明,在组成型表达 Rho 的卵巢癌细胞中,腹膜播散更为显着。这些发现表明 Rho 的上调至关重要。卵巢癌的肿瘤进展,并将成为未来治疗的分子靶点。

项目成果

期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tsuruta Y., et al.: "Combination effect of adenoviral-mediated pro-apoptotic Bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines."Eur J Cancer. 37. 531-541 (2001)
Tsuruta Y.等人:“在卵巢癌细胞系中,腺病毒介导的促凋亡 Bax 基因转移与顺铂或紫杉醇治疗的组合效应。”Eur J Cancer。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsuruta, Y., et al.: "Combination effect of adenovirus-mediated pro-apoptotic"European Journal of Cancer. 37. 531-541 (2001)
Tsuruta,Y.,等人:“腺病毒介导的促细胞凋亡的组合效应”欧洲癌症杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Horiuchi A., et al.: "Toward understanding natural history of ovarian carcinoma development: a clinicopathological approach."Gynecol Oncol. (in press) (2003)
Horiuchi A. 等人:“了解卵巢癌发展的自然史:临床病理学方法。”Gynecol Oncol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Konishi I., et al.: "Gonadotropin hypothesis for development of epithelial ovarian carcinoma: a review."9th Biennial Meeting of IGCS. 113-116 (2002)
Konishi I. 等人:“上皮性卵巢癌发生的促性腺激素假说:综述。”IGCS 第九届双年度会议。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
小西 郁生: "卵巣癌"臨床婦人科産科. 55. 1181-1121 (2001)
小西育夫:“卵巢癌”临床妇产科 55. 1181-1121 (2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KONISHI Ikuo其他文献

KONISHI Ikuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KONISHI Ikuo', 18)}}的其他基金

Develop of ovarian cancer stem cell specific immunotherapy based on DNA microarray analysis
基于DNA微阵列分析的卵巢癌干细胞特异性免疫疗法的开发
  • 批准号:
    23659777
  • 财政年份:
    2011
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Evolution of ovarian carcinoma cells through peritoneal dissemination ; genome-wide analysis and clinical application.
卵巢癌细胞通过腹膜播散的进化;
  • 批准号:
    21390452
  • 财政年份:
    2009
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of signaling pathways in peritoneal dissemination of ovarian cancer, which leads to investigation for their suppressor reagents.
分析卵巢癌腹膜传播的信号通路,从而研究其抑制试剂。
  • 批准号:
    19390426
  • 财政年份:
    2007
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a new molecular target therapy for ovarian carcinoma based on the analyses of mechanisms for its peritoneal dissemination
基于卵巢癌腹膜播散机制分析开发新型分子靶向治疗
  • 批准号:
    15390502
  • 财政年份:
    2003
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of novel gene therapy based on the analysis of anti-apoptotic signals in ovarian cancer
基于卵巢癌抗凋亡信号分析的新型基因疗法的开发
  • 批准号:
    11470347
  • 财政年份:
    1999
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Clinicopathological and Molecular Analyses for Possible Correlation between Infertility Therapy and Development of Ocarian Cancer
不孕症治疗与 Ocarian 癌发展之间可能相关性的临床病理学和分子分析
  • 批准号:
    09470358
  • 财政年份:
    1997
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular-pathologic and clinicopathologic study on the heterogeneity of early development and progression of ovarian cancer
卵巢癌早期发生发展异质性的分子病理学和临床病理学研究
  • 批准号:
    07457608
  • 财政年份:
    1995
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of Heat Shock Proteins in Physiology and Pathology of the Female Genital Tract
热激蛋白在女性生殖道生理学和病理学中的作用
  • 批准号:
    05454447
  • 财政年份:
    1993
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Study on pathogenesis of endometrial carcinomas based on the analysis of growth and differentiation of endometrial gland
从子宫内膜腺生长分化分析子宫内膜癌发病机制
  • 批准号:
    03670781
  • 财政年份:
    1991
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Intraperitoneal immune microenvironment in patients with peritoneal dissemination and its therapeutic application
腹膜播散患者腹腔内免疫微环境及其治疗应用
  • 批准号:
    23K08117
  • 财政年份:
    2023
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of innovative therapies targeting tumor heterogeneity and tumor microenvironment in peritoneal dissemination of gastric cancer
针对胃癌腹膜播散中肿瘤异质性和肿瘤微环境的创新疗法的开发
  • 批准号:
    20K07594
  • 财政年份:
    2020
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Impact of intraperitoneal tumor microenvironment on peritoneal dissemination of gastric cancer via involvement of extracellular vesicles
腹膜内肿瘤微环境通过细胞外囊泡参与对胃癌腹膜播散的影响
  • 批准号:
    18K08679
  • 财政年份:
    2018
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of microenvironment induction mechanism by exosome in liver metastasis and peritoneal dissemination of colorectal cancer
阐明外泌体在结直肠癌肝转移和腹膜播散中的微环境诱导机制
  • 批准号:
    17K10636
  • 财政年份:
    2017
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a new molecular target therapy for ovarian carcinoma based on the analyses of mechanisms for its peritoneal dissemination
基于卵巢癌腹膜播散机制分析开发新型分子靶向治疗
  • 批准号:
    15390502
  • 财政年份:
    2003
  • 资助金额:
    $ 9.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了